Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

NCT00002980 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous Condition
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: decitabine

Sponsor

California Cancer Consortium

Collaborators

[object Object]